Venlafaxine
Generic name: Pronounced as (ven' la fax een)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 01/15/2022
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as venlafaxine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 18 years of age should not normally take venlafaxine, but in some cases, a doctor may decide that venlafaxine is the best medication to treat a child's condition.
You should know that your mental health may change in unexpected ways when you take venlafaxine or other antidepressants even if you are an adult over 24 years of age. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.
Your healthcare provider will want to see you often while you are taking venlafaxine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.
The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with venlafaxine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm.
No matter your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.
Why is this medication prescribed?
Venlafaxine is used to treat depression. Venlafaxine extended-release (long-acting) capsules are also used to treat generalized anxiety disorder (GAD; excessive worrying that is difficult to control), social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life), and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Venlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance.
How should this medicine be used?
Venlafaxine comes as a tablet or extended-release capsule to take by mouth. The tablet is usually taken two or three times a day with food. The extended-release capsule is usually taken once daily in the morning or evening with food. Take venlafaxine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take venlafaxine exactly as directed. Do not take more or less of it or take it more often or for a longer period of time than prescribed by your doctor.
Swallow the extended-release capsule whole; do not split, chew, or crush it, or place it in water. If you cannot swallow the extended-release capsule, you may carefully open the capsule and sprinkle the entire contents on a spoonful of applesauce. Swallow (without chewing) this mixture immediately after preparation and then drink a glass of water to make sure that you have swallowed all of the medication.
Your doctor will probably start you on a low dose of venlafaxine and gradually increase your dose, not more often than once every 4 to 7 days. Tell your doctor how you are feeling during your treatment so that your doctor can adjust your dose properly.
Venlafaxine controls depression but does not cure it. It may take several weeks or longer for you to feel the full benefit of this medication. Continue to take venlafaxine even if you feel well. Do not stop taking venlafaxine without talking to your doctor. Your doctor will probably decrease your dose gradually. If you suddenly stop taking venlafaxine, you may experience withdrawal symptoms such as agitation; anxiety; tiredness; confusion; mood changes; headache; dizziness; irritability; frenzied or abnormal excitement; lack of coordination; trouble falling asleep or staying asleep; nightmares; nausea; vomiting; loss of appetite; diarrhea; dry mouth; sweating; uncontrollable shaking of a part of the body; ringing in the ears; blurred vision; seizures; or burning, tingling, numbness, or electric shock-like feelings in any part of the body. Tell your doctor if you experience any of these symptoms while you are decreasing your dose of venlafaxine or soon after you stop taking venlafaxine.
Other uses for this medicine
Venlafaxine is also sometimes used to treat hot flashes (hot flushes; sudden strong feelings of heat and sweating) in women who have experienced menopause ('change of life'; the end of monthly menstrual periods) or who are taking medication to treat breast cancer. Talk to your doctor or pharmacist about the risks of using venlafaxine to treat your condition.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking venlafaxine,
-
tell your doctor and pharmacist if you are allergic to venlafaxine, any other medications, or any of the ingredients in venlafaxine tablets or extended-release capsules. Ask your pharmacist for a list of the ingredients.
-
you should know that desvenlafaxine is very similar to another SNRI, desvenlafaxine (Pristiq). You should not take these medications together.
-
tell your doctor if you are taking a monoamine oxidase (MAO) inhibitor, such as isocarboxazid (Marplan), linezolid (Zyvox), methylene blue, phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate), or if you have stopped taking one of these medications within the past 14 days. Your doctor will probably tell you that you should not take venlafaxine. If you stop taking venlafaxine, your doctor will tell you that you should wait at least 7 days before you start to take an MAO inhibitor.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, and vitamins you are taking or plan to take. Be sure to mention any of the following: amphetamines such as amphetamine (in Adderall, in Mydayis), dextroamphetamine (Dexedrine, in Adderall), and methamphetamine (Desoxyn); anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); buspirone; cimetidine (Tagamet); clozapine (Clozaril); diuretics ('water pills'); fentanyl (Actiq, Duragesic, Fentora, Subsys); haloperidol (Haldol); indinavir (Crixivan); ketoconazole; lithium; medications for anxiety, mental illness, pain, seizures, or weight loss; medications for migraine such as almotriptan, eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt), sumatriptan (Imitrex), and zolmitriptan (Zomig); metoprolol (Kapspargo Sprinkle, Lopressor, Toprol); mirtazapine (Remeron); phentermine (Adipex P, Lomaira, Qsymia); sedatives; selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, in Symbyax), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft); other SNRIs such as duloxetine (Cymbalta); sleeping pills; tramadol (Conzip, Qdola, Ultram in Ultracet); tranquilizers, and tricyclic antidepressants such as amitriptyline, amoxapine, clomipramine (Anafranil), desipramine (Norpramin), doxepin (Silenor), imipramine (Tofranil), nortriptyline (Pamelor), protriptyline, and trimipramine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor what nutritional supplements and herbal products you are taking, especially St. John's wort and tryptophan.
-
tell your doctor if you have ever used illegal drugs or overused prescription medications. Also tell your doctor if you have recently had a heart attack and if you have or have ever had high blood pressure, high blood cholesterol seizures, glaucoma (increased pressure in the eye that may cause loss of sight), or heart, kidney, liver, or thyroid disease.
-
tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breast-feeding. If you become pregnant while taking venlafaxine, call your doctor. Venlafaxine may cause problems in newborns following delivery if it is taken during the last months of pregnancy.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking venlafaxine.
-
you should know that this medication may make you drowsy and may affect your judgment, thinking, and movements. Do not drive a car or operate machinery until you know how this medication affects you.
-
remember that alcohol can add to the drowsiness caused by this medication.
-
you should know that venlafaxine may cause high blood pressure. You should have your blood pressure checked before starting treatment and regularly while you are taking this medication.
-
you should know that venlafaxine may cause angle-closure glaucoma (a condition where the fluid is suddenly blocked and unable to flow out of the eye causing a quick, severe increase in eye pressure which may lead to a loss of vision). Talk to your doctor about having an eye examination before you start taking this medication. If you have nausea, eye pain, changes in vision, such as seeing colored rings around lights, and swelling or redness in or around the eye, call your doctor or get emergency medical treatment right away.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are taking the extended-release capsules, do not take more than one dose per day.
What side effects can this medication cause?
-
Venlafaxine may cause side effects. Call your doctor if any of the following symptoms are severe or do not go away:
-
drowsiness
-
weakness or tiredness
-
dizziness
-
headache
-
nightmares
-
nausea
-
vomiting
-
stomach pain
-
constipation
-
diarrhea
-
gas
-
heartburn
-
burping
-
dry mouth
-
change in ability to taste food
-
loss of appetite
-
weight loss
-
uncontrollable shaking of a part of the body
-
pain, burning, numbness, or tingling in part of the body
-
yawning
-
sweating
-
hot flashes or flushing
-
frequent urination
-
difficulty urinating
-
sore throat, chills, or other signs of infection
-
ringing in the ears
-
sexual problems in males; decreased sex drive, inability to get or keep an erection, or delayed or absent ejaculation
-
sexual problems in females; decreased sex drive, or delayed orgasm or unable to have an orgasm
-
enlarged pupils (black circles in the middle of the eyes)
-
-
Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately:
-
rash
-
hives
-
itching
-
difficulty breathing or swallowing
-
chest pain
-
fast, pounding, or irregular heartbeat
-
seizures
-
unusual bruising or bleeding
-
small purple spots on the skin
-
fever, sweating, confusion, fast or irregular heartbeat, severe muscle stiffness or twitching, nausea, vomiting, or diarrhea
-
problems with coordination
-
hallucinations (seeing things or hearing voices that do not exist)
-
coma (loss of consciousness for a period of time)
-
-
Venlafaxine may slow growth and weight gain in children. If your child is taking venlafaxine, your child's doctor will watch your child's growth carefully. Talk to your child's doctor about the risks of giving venlafaxine to your child.
-
Venlafaxine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
dizziness
-
nausea
-
vomiting
-
burning, tingling, or numbness of the hands and feet
-
increased size of the pupil (black center of the eye)
-
muscle pain
-
hot and cold spells
-
sleepiness
-
seizures
-
fast, slow, or irregular heartbeat
-
coma (loss of consciousness for a period of time)
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Moxifloxacin. |
Repaglinide | Repaglinide The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Repaglinide. |
Montelukast | Montelukast The metabolism of Montelukast can be decreased when combined with Venlafaxine. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Venlafaxine. |
Leflunomide | Leflunomide The metabolism of Venlafaxine can be decreased when combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Venlafaxine can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Venlafaxine can be decreased when combined with Nevirapine. |
Dolasetron | Dolasetron The metabolism of Dolasetron can be decreased when combined with Venlafaxine. |
Anagrelide | Anagrelide The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Anagrelide. |
Candesartan | Candesartan The metabolism of Venlafaxine can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Venlafaxine. |
Clopidogrel | Clopidogrel The metabolism of Venlafaxine can be decreased when combined with Clopidogrel. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diphenoxylate. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Venlafaxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate The metabolism of Venlafaxine can be decreased when combined with Fenofibrate. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Guanfacine. |
Magnesium Hydroxide | Magnesium Hydroxide Venlafaxine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Miglitol | Miglitol The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Miglitol. |
Mycophenolate | Mycophenolate Venlafaxine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Venlafaxine is combined with Morphine. |
Penbutolol | Penbutolol The metabolism of Acebutolol can be decreased when combined with Venlafaxine. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pentazocine. |
Potassium | Potassium Potassium may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Venlafaxine may decrease the excretion rate of Prednisone which could result in a higher serum level. |
Ranitidine | Ranitidine The metabolism of Venlafaxine can be decreased when combined with Ranitidine. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Venlafaxine. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rizatriptan. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sumatriptan. |
Tacrolimus | Tacrolimus Tacrolimus may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tizanidine. |
Zolmitriptan | Zolmitriptan The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Zolmitriptan. |
Ampicillin Injection | Ampicillin Injection Venlafaxine may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Famotidine Injection | Famotidine Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Famotidine. |
Fluconazole Injection | Fluconazole Injection The metabolism of Venlafaxine can be decreased when combined with Fluconazole. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Hydromorphone. |
Levofloxacin Injection | Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Levofloxacin. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be decreased when combined with Venlafaxine. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine. |
Metronidazole Injection | Metronidazole Injection The metabolism of Venlafaxine can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Morphine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Venlafaxine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection Venlafaxine may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy. |
Altretamine | Altretamine The metabolism of Venlafaxine can be decreased when combined with Amphetamine. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Venlafaxine. |
Ondansetron | Ondansetron The metabolism of Ondansetron can be decreased when combined with Venlafaxine. |
Enoxaparin Injection | Enoxaparin Injection Venlafaxine may increase the antiplatelet activities of Enoxaparin. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Venlafaxine is combined with Granisetron. |
Torsemide | Torsemide The metabolism of Venlafaxine can be decreased when combined with Torasemide. |
Olanzapine | Olanzapine The metabolism of Olanzapine can be decreased when combined with Venlafaxine. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alosetron. |
Dofetilide | Dofetilide The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Dofetilide. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Entacapone. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Venlafaxine can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam Venlafaxine may increase the antiplatelet activities of Meloxicam. |
Oxcarbazepine | Oxcarbazepine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Temozolomide | Temozolomide Venlafaxine may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zaleplon. |
Anakinra | Anakinra The metabolism of Venlafaxine can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Desloratadine. |
Linezolid | Linezolid Linezolid may increase the serotonergic activities of Venlafaxine. |
Pentosan Polysulfate | Pentosan Polysulfate Venlafaxine may increase the antiplatelet activities of Pentosan polysulfate. |
Trimipramine | Trimipramine The metabolism of Trimipramine can be decreased when combined with Venlafaxine. |
Etanercept Injection | Etanercept Injection The metabolism of Venlafaxine can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Modafinil | Modafinil The metabolism of Venlafaxine can be decreased when combined with Armodafinil. |
Perindopril | Perindopril Venlafaxine may decrease the excretion rate of Perindopril which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Venlafaxine may increase the antiplatelet activities of Choline magnesium trisalicylate. |
Epinephrine Injection | Epinephrine Injection Venlafaxine may increase the tachycardic activities of Epinephrine. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Escitalopram. |
Zonisamide | Zonisamide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Venlafaxine can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Venlafaxine. |
Atomoxetine | Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Venlafaxine. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dexmethylphenidate. |
Ezetimibe | Ezetimibe Venlafaxine may increase the excretion rate of Ezetimibe which could result in a lower serum level and potentially a reduction in efficacy. |
Atazanavir | Atazanavir The metabolism of Venlafaxine can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan The metabolism of Almotriptan can be decreased when combined with Venlafaxine. |
Eletriptan | Eletriptan The metabolism of Eletriptan can be decreased when combined with Venlafaxine. |
Mefloquine | Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Venlafaxine. |
Rosuvastatin | Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Venlafaxine. |
Vardenafil | Vardenafil The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Vardenafil. |
Alfuzosin | Alfuzosin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Alfuzosin. |
Aprepitant | Aprepitant The metabolism of Venlafaxine can be decreased when combined with Aprepitant. |
Emtricitabine | Emtricitabine Venlafaxine may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Venlafaxine may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tegaserod | Tegaserod The metabolism of Tegaserod can be decreased when combined with Venlafaxine. |
Tadalafil | Tadalafil Venlafaxine may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan. |
Gemifloxacin | Gemifloxacin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Gemifloxacin. |
Progesterone | Progesterone The metabolism of Progesterone can be decreased when combined with Venlafaxine. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Apomorphine. |
Infliximab Injection | Infliximab Injection The metabolism of Venlafaxine can be increased when combined with Infliximab. |
Oxandrolone | Oxandrolone The metabolism of Venlafaxine can be decreased when combined with Oxandrolone. |
Protriptyline | Protriptyline The metabolism of Protriptyline can be decreased when combined with Venlafaxine. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Venlafaxine. |
Tinidazole | Tinidazole Venlafaxine may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Trospium | Trospium Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Bosentan | Bosentan The metabolism of Venlafaxine can be increased when combined with Bosentan. |
Cefditoren | Cefditoren Venlafaxine may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Venlafaxine can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Venlafaxine. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Venlafaxine is combined with Eszopiclone. |
Ganciclovir | Ganciclovir Venlafaxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin aspart. |
Ribavirin | Ribavirin Venlafaxine may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin The metabolism of Solifenacin can be decreased when combined with Venlafaxine. |
Valganciclovir | Valganciclovir Venlafaxine may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The risk or severity of adverse effects can be increased when Voriconazole is combined with Venlafaxine. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The metabolism of Venlafaxine can be decreased when combined with Amphetamine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Venlafaxine can be increased when combined with Peginterferon alfa-2b. |
Pramlintide Injection | Pramlintide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pramlintide. |
Sodium Oxybate | Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Exenatide Injection | Exenatide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Exenatide. |
Ibandronate | Ibandronate The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid Venlafaxine may increase the serotonergic activities of Isocarboxazid. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ramelteon. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Venlafaxine. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fentanyl. |
Pregabalin | Pregabalin The therapeutic efficacy of Venlafaxine can be increased when used in combination with Pregabalin. |
Phenylephrine | Phenylephrine Venlafaxine may increase the tachycardic activities of Phenylephrine. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Venlafaxine. |
Felbamate | Felbamate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Felbamate. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin detemir. |
Ranolazine | Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Venlafaxine. |
Abatacept Injection | Abatacept Injection The metabolism of Venlafaxine can be increased when combined with Abatacept. |
Rasagiline | Rasagiline Rasagiline may increase the serotonergic activities of Venlafaxine. |
Imatinib | Imatinib The metabolism of Imatinib can be decreased when combined with Venlafaxine. |
Sitagliptin | Sitagliptin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sitagliptin. |
Varenicline | Varenicline Venlafaxine may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Gefitinib | Gefitinib The metabolism of Gefitinib can be decreased when combined with Venlafaxine. |
Albuterol | Albuterol Venlafaxine may increase the tachycardic activities of Salbutamol. |
Paliperidone | Paliperidone The metabolism of Paliperidone can be decreased when combined with Venlafaxine. |
Bortezomib | Bortezomib The metabolism of Venlafaxine can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Venlafaxine may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin glulisine. |
Lubiprostone | Lubiprostone Venlafaxine may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Oxaliplatin. |
Posaconazole | Posaconazole The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Venlafaxine can be decreased when combined with Primaquine. |
Pemetrexed Injection | Pemetrexed Injection Venlafaxine may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dimenhydrinate. |
Lisdexamfetamine | Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Venlafaxine. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Vorinostat | Vorinostat The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Vorinostat. |
Sorafenib | Sorafenib The metabolism of Venlafaxine can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sunitinib. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Lapatinib | Lapatinib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Venlafaxine may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Dasatinib. |
Mexiletine | Mexiletine The metabolism of Mexiletine can be decreased when combined with Venlafaxine. |
Armodafinil | Armodafinil The metabolism of Venlafaxine can be decreased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection Venlafaxine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ivermectin | Ivermectin Venlafaxine may increase the excretion rate of Ivermectin which could result in a lower serum level and potentially a reduction in efficacy. |
Temsirolimus | Temsirolimus The metabolism of Venlafaxine can be decreased when combined with Temsirolimus. |
Lenalidomide | Lenalidomide Venlafaxine may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Venlafaxine. |
Toremifene | Toremifene The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Toremifene. |
Bexarotene | Bexarotene The metabolism of Bexarotene can be decreased when combined with Venlafaxine. |
Budesonide | Budesonide Venlafaxine may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Venlafaxine. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Venlafaxine. |
Doripenem Injection | Doripenem Injection Venlafaxine may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Etravirine | Etravirine The metabolism of Venlafaxine can be decreased when combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection Venlafaxine may increase the excretion rate of Mitoxantrone which could result in a lower serum level and potentially a reduction in efficacy. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Desvenlafaxine. |
Cevimeline | Cevimeline The metabolism of Venlafaxine can be decreased when combined with Cevimeline. |
Nebivolol | Nebivolol The metabolism of Nebivolol can be decreased when combined with Venlafaxine. |
Tretinoin | Tretinoin The metabolism of Tretinoin can be decreased when combined with Venlafaxine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Venlafaxine. |
Certolizumab Injection | Certolizumab Injection The metabolism of Venlafaxine can be increased when combined with Certolizumab pegol. |
Irinotecan Injection | Irinotecan Injection Venlafaxine may increase the excretion rate of Irinotecan which could result in a lower serum level and potentially a reduction in efficacy. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Venlafaxine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Venlafaxine. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Midazolam. |
Naltrexone Injection | Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Naltrexone. |
Dexrazoxane Injection | Dexrazoxane Injection Venlafaxine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Venlafaxine is combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Venlafaxine may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Venlafaxine. |
Degarelix Injection | Degarelix Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Degarelix. |
Betaxolol | Betaxolol The metabolism of Betaxolol can be decreased when combined with Venlafaxine. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Venlafaxine. |
Prasugrel | Prasugrel Venlafaxine may increase the antiplatelet activities of Prasugrel. |
Lacosamide | Lacosamide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lacosamide. |
Everolimus | Everolimus The metabolism of Venlafaxine can be decreased when combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Venlafaxine. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Venlafaxine. |
Pralatrexate Injection | Pralatrexate Injection Venlafaxine may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Venlafaxine. |
Saxagliptin | Saxagliptin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Saxagliptin. |
Telavancin Injection | Telavancin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Telavancin. |
Romidepsin Injection | Romidepsin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Romidepsin. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Topotecan | Topotecan Venlafaxine may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Golimumab Injection | Golimumab Injection The metabolism of Venlafaxine can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Venlafaxine. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Asenapine. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vigabatrin. |
Pitavastatin | Pitavastatin Venlafaxine may increase the excretion rate of Pitavastatin which could result in a lower serum level and potentially a reduction in efficacy. |
Oxymorphone | Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Venlafaxine. |
Dabigatran | Dabigatran Venlafaxine may increase the antiplatelet activities of Dabigatran. |
Liraglutide Injection | Liraglutide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Liraglutide. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Venlafaxine can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine The risk or severity of seizure can be increased when Venlafaxine is combined with Dalfampridine. |
Eribulin Injection | Eribulin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Eribulin. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Venlafaxine. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Venlafaxine. |
Vilazodone | Vilazodone The metabolism of Vilazodone can be decreased when combined with Venlafaxine. |
Ipilimumab Injection | Ipilimumab Injection Venlafaxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Venlafaxine may increase the tachycardic activities of Terbutaline. |
Roflumilast | Roflumilast Venlafaxine may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Linagliptin | Linagliptin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Venlafaxine. |
Telaprevir | Telaprevir Venlafaxine may increase the excretion rate of Glecaprevir which could result in a lower serum level and potentially a reduction in efficacy. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Venlafaxine. |
Abiraterone | Abiraterone The metabolism of Venlafaxine can be decreased when combined with Abiraterone. |
Triptorelin Injection | Triptorelin Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Triptorelin. |
Rivaroxaban | Rivaroxaban Venlafaxine may increase the antiplatelet activities of Rivaroxaban. |
Ticagrelor | Ticagrelor Venlafaxine may increase the antiplatelet activities of Ticagrelor. |
Ruxolitinib | Ruxolitinib Venlafaxine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Vandetanib | Vandetanib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Vandetanib. |
Clobazam | Clobazam The metabolism of Clobazam can be decreased when combined with Venlafaxine. |
Vemurafenib | Vemurafenib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Vemurafenib. |
Vismodegib | Vismodegib The metabolism of Venlafaxine can be decreased when combined with Vismodegib. |
Deferiprone | Deferiprone Venlafaxine may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Crizotinib | Crizotinib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Crizotinib. |
Cabergoline | Cabergoline The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Venlafaxine. |
Naloxone Injection | Naloxone Injection Venlafaxine may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Fondaparinux Injection | Fondaparinux Injection Venlafaxine may increase the antiplatelet activities of Fondaparinux. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tiagabine. |
Iloprost | Iloprost Venlafaxine may increase the antiplatelet activities of Iloprost. |
Enzalutamide | Enzalutamide The metabolism of Venlafaxine can be increased when combined with Enzalutamide. |
Mirabegron | Mirabegron The metabolism of Mirabegron can be decreased when combined with Venlafaxine. |
Regorafenib | Regorafenib The metabolism of Venlafaxine can be decreased when combined with Regorafenib. |
Teriflunomide | Teriflunomide Venlafaxine may increase the excretion rate of Teriflunomide which could result in a lower serum level and potentially a reduction in efficacy. |
Lorcaserin | Lorcaserin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mecasermin. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Venlafaxine. |
Teduglutide Injection | Teduglutide Injection Venlafaxine may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Bedaquiline | Bedaquiline The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Bedaquiline. |
Icosapent Ethyl | Icosapent Ethyl Venlafaxine may increase the antiplatelet activities of Icosapent ethyl. |
Alogliptin | Alogliptin The metabolism of Alogliptin can be decreased when combined with Venlafaxine. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Venlafaxine. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pomalidomide. |
Apixaban | Apixaban Venlafaxine may increase the antiplatelet activities of Apixaban. |
Canagliflozin | Canagliflozin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Canagliflozin. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The metabolism of Venlafaxine can be increased when combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Venlafaxine can be decreased when combined with Ospemifene. |
Trametinib | Trametinib Venlafaxine may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Dolutegravir | Dolutegravir Venlafaxine may increase the excretion rate of Dolutegravir which could result in a lower serum level and potentially a reduction in efficacy. |
Afatinib | Afatinib Venlafaxine may increase the excretion rate of Afatinib which could result in a lower serum level and potentially a reduction in efficacy. |
Levomilnacipran | Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Venlafaxine. |
Ertapenem Injection | Ertapenem Injection Venlafaxine may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Venlafaxine. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Venlafaxine. |
Ketorolac Injection | Ketorolac Injection Venlafaxine may increase the antiplatelet activities of Ketorolac. |
Simeprevir | Simeprevir Venlafaxine may increase the excretion rate of Simeprevir which could result in a lower serum level and potentially a reduction in efficacy. |
Sofosbuvir | Sofosbuvir Venlafaxine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Venlafaxine. |
Apremilast | Apremilast The metabolism of Venlafaxine can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Venlafaxine may increase the tachycardic activities of Droxidopa. |
Ceritinib | Ceritinib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Venlafaxine can be increased when combined with Siltuximab. |
Albiglutide Injection | Albiglutide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Albiglutide. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Eslicarbazepine. |
Idelalisib | Idelalisib Venlafaxine may increase the excretion rate of Idelalisib which could result in a lower serum level and potentially a reduction in efficacy. |
Testosterone Injection | Testosterone Injection Venlafaxine may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Oritavancin Injection | Oritavancin Injection The metabolism of Venlafaxine can be decreased when combined with Oritavancin. |
Empagliflozin | Empagliflozin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Empagliflozin. |
Vorapaxar | Vorapaxar Venlafaxine may increase the antiplatelet activities of Vorapaxar. |
Hydrocodone | Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Suvorexant | Suvorexant Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Dulaglutide Injection | Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Dulaglutide. |
Edoxaban | Edoxaban Venlafaxine may increase the antiplatelet activities of Edoxaban. |
Methamphetamine | Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Venlafaxine. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tasimelteon. |
Riociguat | Riociguat Venlafaxine may increase the excretion rate of Riociguat which could result in a lower serum level and potentially a reduction in efficacy. |
Lanreotide Injection | Lanreotide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Lanreotide. |
Secukinumab Injection | Secukinumab Injection The metabolism of Venlafaxine can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The metabolism of Risperidone can be decreased when combined with Venlafaxine. |
Palbociclib | Palbociclib Venlafaxine may increase the excretion rate of Palbociclib which could result in a lower serum level and potentially a reduction in efficacy. |
Insulin Human Inhalation | Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Insulin human is combined with Venlafaxine. |
Lenvatinib | Lenvatinib The metabolism of Lenvatinib can be decreased when combined with Venlafaxine. |
Naloxegol | Naloxegol The metabolism of Venlafaxine can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Venlafaxine. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Venlafaxine. |
Ivabradine | Ivabradine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ivabradine. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Venlafaxine may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Venlafaxine is combined with Flibanserin. |
Rolapitant | Rolapitant The metabolism of Venlafaxine can be decreased when combined with Rolapitant. |
Brexpiprazole | Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Venlafaxine. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Venlafaxine. |
Cariprazine | Cariprazine The metabolism of Cariprazine can be decreased when combined with Venlafaxine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Venlafaxine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Eluxadoline. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin degludec. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Venlafaxine. |
Osimertinib | Osimertinib Venlafaxine may increase the excretion rate of Osimertinib which could result in a lower serum level and potentially a reduction in efficacy. |
Ixazomib | Ixazomib Venlafaxine may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Venlafaxine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Defibrotide Injection | Defibrotide Injection Venlafaxine may increase the antiplatelet activities of Defibrotide. |
Brivaracetam Injection | Brivaracetam Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Brivaracetam. |
Venetoclax | Venetoclax Venlafaxine may increase the excretion rate of Venetoclax which could result in a lower serum level and potentially a reduction in efficacy. |
Cobicistat | Cobicistat The metabolism of Venlafaxine can be decreased when combined with Cobicistat. |
Midodrine | Midodrine Venlafaxine may increase the tachycardic activities of Midodrine. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Venlafaxine. |
Furosemide Injection | Furosemide Injection Venlafaxine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The metabolism of Venlafaxine can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Lixisenatide. |
Ribociclib | Ribociclib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ribociclib. |
Brigatinib | Brigatinib Venlafaxine may increase the excretion rate of Brigatinib which could result in a lower serum level and potentially a reduction in efficacy. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Venlafaxine. |
Deutetrabenazine | Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Venlafaxine. |
Valbenazine | Valbenazine The metabolism of Valbenazine can be decreased when combined with Venlafaxine. |
Safinamide | Safinamide Safinamide may increase the serotonergic activities of Venlafaxine. |
Naldemedine | Naldemedine Venlafaxine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Venlafaxine can be decreased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Venlafaxine can be decreased when combined with Enasidenib. |
Benznidazole | Benznidazole Venlafaxine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection Venlafaxine may increase the excretion rate of Copanlisib which could result in a lower serum level and potentially a reduction in efficacy. |
Delafloxacin | Delafloxacin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Delafloxacin. |
Abemaciclib | Abemaciclib Venlafaxine may increase the excretion rate of Abemaciclib which could result in a lower serum level and potentially a reduction in efficacy. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Venlafaxine is combined with Betrixaban. |
Letermovir | Letermovir The metabolism of Letermovir can be decreased when combined with Venlafaxine. |
Semaglutide Injection | Semaglutide Injection The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Semaglutide. |
Tetrabenazine | Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Venlafaxine. |
Ertugliflozin | Ertugliflozin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ertugliflozin. |
Buprenorphine Injection | Buprenorphine Injection Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide Apalutamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Avatrombopag | Avatrombopag The metabolism of Venlafaxine can be increased when combined with Avatrombopag. |
Baricitinib | Baricitinib Venlafaxine may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Venlafaxine can be increased when used in combination with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Venlafaxine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Venlafaxine. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Venlafaxine. |
Ivosidenib | Ivosidenib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ivosidenib. |
Lusutrombopag | Lusutrombopag Venlafaxine may increase the excretion rate of Lusutrombopag which could result in a lower serum level and potentially a reduction in efficacy. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Venlafaxine. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Venlafaxine. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Venlafaxine. |
Dacomitinib | Dacomitinib The metabolism of Venlafaxine can be decreased when combined with Dacomitinib. |
Duvelisib | Duvelisib Venlafaxine may increase the excretion rate of Duvelisib which could result in a lower serum level and potentially a reduction in efficacy. |
Stiripentol | Stiripentol The metabolism of Venlafaxine can be decreased when combined with Stiripentol. |
Talazoparib | Talazoparib Venlafaxine may increase the excretion rate of Talazoparib which could result in a lower serum level and potentially a reduction in efficacy. |
Gilteritinib | Gilteritinib The therapeutic efficacy of Venlafaxine can be decreased when used in combination with Gilteritinib. |
Glasdegib | Glasdegib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Glasdegib. |
Rifamycin | Rifamycin The metabolism of Venlafaxine can be decreased when combined with Rifamycin. |
Prucalopride | Prucalopride Venlafaxine may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Venlafaxine can be increased when combined with Emapalumab. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Venlafaxine. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection Venlafaxine may increase the antiplatelet activities of Caplacizumab. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Venlafaxine. |
Alpelisib | Alpelisib The serum concentration of Venlafaxine can be decreased when it is combined with Alpelisib. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Brexanolone. |
Cladribine | Cladribine Venlafaxine may increase the excretion rate of Cladribine which could result in a lower serum level and potentially a reduction in efficacy. |
Solriamfetol | Solriamfetol The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Venlafaxine. |
Darolutamide | Darolutamide Venlafaxine may increase the excretion rate of Darolutamide which could result in a lower serum level and potentially a reduction in efficacy. |
Triclabendazole | Triclabendazole The metabolism of Venlafaxine can be decreased when combined with Triclabendazole. |
Entrectinib | Entrectinib The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Entrectinib. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Venlafaxine. |
Pitolisant | Pitolisant The serum concentration of Venlafaxine can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Venlafaxine can be decreased when combined with Fedratinib. |
Lefamulin | Lefamulin Venlafaxine may increase the QTc-prolonging activities of Lefamulin. |
Phenytoin Injection | Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Venlafaxine. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Venlafaxine. |
Voxelotor | Voxelotor The metabolism of Voxelotor can be decreased when combined with Venlafaxine. |
Avapritinib | Avapritinib The metabolism of Avapritinib can be decreased when combined with Venlafaxine. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lumateperone. |
Lasmiditan | Lasmiditan The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Lasmiditan. |
Ubrogepant | Ubrogepant Venlafaxine may increase the excretion rate of Ubrogepant which could result in a lower serum level and potentially a reduction in efficacy. |
Tazemetostat | Tazemetostat Venlafaxine may increase the excretion rate of Tazemetostat which could result in a lower serum level and potentially a reduction in efficacy. |
Cenobamate | Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Venlafaxine. |
Ozanimod | Ozanimod Venlafaxine may increase the excretion rate of Ozanimod which could result in a lower serum level and potentially a reduction in efficacy. |
Selumetinib | Selumetinib Venlafaxine may increase the excretion rate of Selumetinib which could result in a lower serum level and potentially a reduction in efficacy. |
Rimegepant | Rimegepant Venlafaxine may increase the excretion rate of Rimegepant which could result in a lower serum level and potentially a reduction in efficacy. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Venlafaxine. |
Ripretinib | Ripretinib Venlafaxine may increase the excretion rate of Ripretinib which could result in a lower serum level and potentially a reduction in efficacy. |
Lemborexant | Lemborexant The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Fenfluramine. |
Fostemsavir | Fostemsavir The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Fostemsavir. |
Octreotide | Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Venlafaxine. |
Pralsetinib | Pralsetinib The metabolism of Pralsetinib can be decreased when combined with Venlafaxine. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Venlafaxine can be decreased when it is combined with Satralizumab. |
Relugolix | Relugolix The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Relugolix. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Venlafaxine. |
Fenoprofen | Fenoprofen Venlafaxine may increase the antiplatelet activities of Fenoprofen. |
Indomethacin | Indomethacin Venlafaxine may decrease the excretion rate of Indomethacin which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid Venlafaxine may increase the antiplatelet activities of Mefenamic acid. |
Naproxen | Naproxen Venlafaxine may increase the antiplatelet activities of Naproxen. |
Tolmetin | Tolmetin Venlafaxine may increase the antiplatelet activities of Tolmetin. |
Sulindac | Sulindac Venlafaxine may increase the antiplatelet activities of Sulindac. |
Trazodone | Trazodone Venlafaxine may increase the serotonergic activities of Trazodone. |
Isotretinoin | Isotretinoin Venlafaxine may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Venlafaxine may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The metabolism of Venlafaxine can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine The metabolism of Venlafaxine can be decreased when combined with Floxuridine. |
Phenobarbital | Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Venlafaxine. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Metaxalone. |
Methotrexate Injection | Methotrexate Injection Venlafaxine may decrease the excretion rate of Methotrexate which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levorphanol. |
Primidone | Primidone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Primidone. |
Methsuximide | Methsuximide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diethylpropion. |
Chlorpromazine | Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Venlafaxine. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diazepam. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxazepam. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Flurazepam. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clorazepic acid. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Venlafaxine. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Amantadine | Amantadine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Amantadine. |
Codeine | Codeine The metabolism of Codeine can be decreased when combined with Venlafaxine. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Venlafaxine is combined with Meprobamate. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlordiazepoxide. |
Bromocriptine | Bromocriptine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Bromocriptine. |
Metaproterenol | Metaproterenol Venlafaxine may increase the tachycardic activities of Orciprenaline. |
Tranylcypromine | Tranylcypromine The metabolism of Tranylcypromine can be decreased when combined with Venlafaxine. |
Phenelzine | Phenelzine Venlafaxine may increase the serotonergic activities of Phenelzine. |
Procarbazine | Procarbazine Procarbazine may increase the serotonergic activities of Venlafaxine. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ergoloid mesylate. |
Tetracycline | Tetracycline Venlafaxine may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Prochlorperazine | Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Venlafaxine. |
Thioridazine | Thioridazine The metabolism of Thioridazine can be decreased when combined with Venlafaxine. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trifluoperazine. |
Bleomycin | Bleomycin Venlafaxine may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Dapsone | Dapsone The metabolism of Venlafaxine can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfadiazine. |
Oxycodone | Oxycodone The metabolism of Oxycodone can be decreased when combined with Venlafaxine. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Venlafaxine. |
Oxybutynin | Oxybutynin The metabolism of Venlafaxine can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine The metabolism of Venlafaxine can be decreased when combined with Benzatropine. |
Maprotiline | Maprotiline The metabolism of Maprotiline can be decreased when combined with Venlafaxine. |
Ibuprofen | Ibuprofen Venlafaxine may decrease the excretion rate of Ibuprofen which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Perphenazine can be decreased when combined with Venlafaxine. |
Azathioprine | Azathioprine Venlafaxine may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fluphenazine. |
Phentermine | Phentermine The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Venlafaxine. |
Methylphenidate | Methylphenidate Venlafaxine may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Amoxapine | Amoxapine The metabolism of Amoxapine can be decreased when combined with Venlafaxine. |
Sulfasalazine | Sulfasalazine Venlafaxine may increase the antiplatelet activities of Sulfasalazine. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Venlafaxine. |
Dactinomycin | Dactinomycin Venlafaxine may increase the excretion rate of Dactinomycin which could result in a lower serum level and potentially a reduction in efficacy. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Carbamazepine | Carbamazepine Venlafaxine may decrease the excretion rate of Carbamazepine which could result in a higher serum level. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Molindone. |
Methyldopa | Methyldopa Venlafaxine may increase the tachycardic activities of Methyldopa. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Venlafaxine. |
Prazosin | Prazosin Venlafaxine may increase the excretion rate of Prazosin which could result in a lower serum level and potentially a reduction in efficacy. |
Hydralazine | Hydralazine Venlafaxine may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine The metabolism of Cimetidine can be decreased when combined with Venlafaxine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Warfarin | Warfarin The metabolism of Venlafaxine can be decreased when combined with Warfarin. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clonazepam. |
Loperamide | Loperamide The metabolism of Venlafaxine can be decreased when combined with Loperamide. |
Promethazine | Promethazine The metabolism of Promethazine can be decreased when combined with Venlafaxine. |
Meclofenamate | Meclofenamate Venlafaxine may increase the antiplatelet activities of Meclofenamic acid. |
Daunorubicin | Daunorubicin Venlafaxine may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy. |
Nitrofurantoin | Nitrofurantoin Venlafaxine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Venlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Loxapine. |
Chloroquine | Chloroquine The metabolism of Chloroquine can be decreased when combined with Venlafaxine. |
Quinine | Quinine The metabolism of Quinine can be decreased when combined with Venlafaxine. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ethosuximide. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Venlafaxine can be decreased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Venlafaxine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital The risk or severity of adverse effects can be increased when Venlafaxine is combined with Secobarbital. |
Desipramine | Desipramine The serum concentration of the active metabolites of Desipramine can be increased when Desipramine is used in combination with Venlafaxine. |
Amitriptyline | Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Venlafaxine. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Venlafaxine. |
Probenecid | Probenecid The metabolism of Probenecid can be decreased when combined with Venlafaxine. |
Quinidine | Quinidine The metabolism of Venlafaxine can be decreased when combined with Quinidine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Venlafaxine. |
Isoniazid | Isoniazid The metabolism of Venlafaxine can be decreased when combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Venlafaxine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Disopyramide. |
Valproic Acid | Valproic Acid The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Venlafaxine. |
Butabarbital | Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Venlafaxine. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Methimazole | Methimazole The metabolism of Venlafaxine can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Chlorpropamide. |
Tolbutamide | Tolbutamide The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tolbutamide. |
Tolazamide | Tolazamide The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tolazamide. |
Dextromethorphan | Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Venlafaxine. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cyclobenzaprine. |
Niacin | Niacin The metabolism of Venlafaxine can be decreased when combined with Niacin. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Venlafaxine. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine. |
Cyproheptadine | Cyproheptadine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine. |
Clemastine | Clemastine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Venlafaxine. |
Brompheniramine | Brompheniramine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine. |
Meclizine | Meclizine The metabolism of Meclizine can be decreased when combined with Venlafaxine. |
Ethambutol | Ethambutol Venlafaxine may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Venlafaxine. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Venlafaxine. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methocarbamol. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Disulfiram | Disulfiram The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Venlafaxine. |
Pseudoephedrine | Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Pseudoephedrine. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Venlafaxine. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Phytonadione | Phytonadione Venlafaxine may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Nadolol | Nadolol The metabolism of Nadolol can be decreased when combined with Venlafaxine. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Butorphanol. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nalbuphine. |
Allopurinol | Allopurinol Venlafaxine may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Oxytocin Injection | Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Venlafaxine. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trimethobenzamide. |
Flavoxate | Flavoxate Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate. |
Papaverine | Papaverine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Papaverine. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Fluorouracil. |
Colchicine | Colchicine Venlafaxine may decrease the excretion rate of Colchicine which could result in a higher serum level. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Dacarbazine | Dacarbazine Venlafaxine may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Venlafaxine is combined with Acetazolamide. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Ketoconazole | Ketoconazole The serum concentration of Venlafaxine can be increased when it is combined with Ketoconazole. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pyrantel. |
Vincristine Injection | Vincristine Injection Venlafaxine may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy. |
Dipyridamole | Dipyridamole Venlafaxine may increase the antiplatelet activities of Dipyridamole. |
Isoxsuprine | Isoxsuprine Venlafaxine may increase the tachycardic activities of Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Venlafaxine can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Metoprolol | Metoprolol The serum concentration of Venlafaxine can be increased when it is combined with Metoprolol. |
Hydroxyzine | Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Venlafaxine. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiothixene. |
Aspirin | Aspirin Venlafaxine may increase the antiplatelet activities of Acetylsalicylic acid. |
Salsalate | Salsalate Venlafaxine may increase the antiplatelet activities of Salsalate. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alprazolam. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Venlafaxine. |
Triazolam | Triazolam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triazolam. |
Dicyclomine | Dicyclomine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine. |
Hyoscyamine | Hyoscyamine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Propantheline. |
Trimethoprim | Trimethoprim Venlafaxine may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem The metabolism of Diltiazem can be decreased when combined with Venlafaxine. |
Nifedipine | Nifedipine The metabolism of Nifedipine can be decreased when combined with Venlafaxine. |
Timolol | Timolol The metabolism of Timolol can be decreased when combined with Venlafaxine. |
Verapamil | Verapamil The metabolism of Venlafaxine can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Atenolol can be decreased when combined with Venlafaxine. |
Pindolol | Pindolol The metabolism of Pindolol can be decreased when combined with Venlafaxine. |
Cisplatin Injection | Cisplatin Injection Venlafaxine may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Venlafaxine may increase the antiplatelet activities of Diflunisal. |
Piroxicam | Piroxicam Venlafaxine may increase the antiplatelet activities of Piroxicam. |
Bumetanide | Bumetanide Venlafaxine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy. |
Etoposide | Etoposide Venlafaxine may increase the excretion rate of Etoposide which could result in a lower serum level and potentially a reduction in efficacy. |
Glyburide | Glyburide The metabolism of Glyburide can be decreased when combined with Venlafaxine. |
Glipizide | Glipizide The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glipizide. |
Indapamide | Indapamide Venlafaxine may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Venlafaxine may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Venlafaxine may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Venlafaxine may increase the antiplatelet activities of Pentoxifylline. |
Pentamidine Injection | Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Venlafaxine. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Labetalol | Labetalol The metabolism of Labetalol can be decreased when combined with Venlafaxine. |
Auranofin | Auranofin Venlafaxine may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Leuprolide. |
Gemfibrozil | Gemfibrozil The metabolism of Venlafaxine can be decreased when combined with Gemfibrozil. |
Guanabenz | Guanabenz Venlafaxine may increase the tachycardic activities of Guanabenz. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Ketoprofen | Ketoprofen Venlafaxine may increase the antiplatelet activities of Ketoprofen. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Venlafaxine. |
Flurbiprofen | Flurbiprofen Venlafaxine may increase the antiplatelet activities of Flurbiprofen. |
Amiodarone | Amiodarone The metabolism of Venlafaxine can be decreased when combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Venlafaxine may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone The metabolism of Buspirone can be decreased when combined with Venlafaxine. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Venlafaxine. |
Ciprofloxacin | Ciprofloxacin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ciprofloxacin. |
Mesalamine | Mesalamine Venlafaxine may increase the antiplatelet activities of Mesalazine. |
Diclofenac | Diclofenac Venlafaxine may increase the antiplatelet activities of Diclofenac. |
Fluoxetine | Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Venlafaxine. |
Nimodipine | Nimodipine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Nimodipine. |
Clozapine | Clozapine The metabolism of Clozapine can be decreased when combined with Venlafaxine. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Estazolam. |
Idarubicin | Idarubicin The metabolism of Idarubicin can be decreased when combined with Venlafaxine. |
Ofloxacin | Ofloxacin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ofloxacin. |
Didanosine | Didanosine Venlafaxine may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Venlafaxine may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Clarithromycin | Clarithromycin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Clarithromycin. |
Etodolac | Etodolac Venlafaxine may increase the antiplatelet activities of Etodolac. |
Felodipine | Felodipine The metabolism of Felodipine can be decreased when combined with Venlafaxine. |
Fosinopril | Fosinopril Venlafaxine may decrease the excretion rate of Fosinopril which could result in a higher serum level. |
Nabumetone | Nabumetone Venlafaxine may increase the antiplatelet activities of Nabumetone. |
Pravastatin | Pravastatin Venlafaxine may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy. |
Simvastatin | Simvastatin The metabolism of Simvastatin can be decreased when combined with Venlafaxine. |
Teniposide Injection | Teniposide Injection The metabolism of Teniposide can be decreased when combined with Venlafaxine. |
Itraconazole | Itraconazole The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Itraconazole. |
Lisinopril | Lisinopril Venlafaxine may decrease the excretion rate of Lisinopril which could result in a higher serum level. |
Oxaprozin | Oxaprozin Venlafaxine may increase the antiplatelet activities of Oxaprozin. |
Atovaquone | Atovaquone The metabolism of Venlafaxine can be decreased when combined with Atovaquone. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Venlafaxine. |
Bisoprolol | Bisoprolol Venlafaxine may decrease the excretion rate of Bisoprolol which could result in a higher serum level. |
Zolpidem | Zolpidem Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Doxazosin | Doxazosin The metabolism of Venlafaxine can be decreased when combined with Doxazosin. |
Isradipine | Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Venlafaxine. |
Omeprazole | Omeprazole The metabolism of Omeprazole can be decreased when combined with Venlafaxine. |
Cisapride | Cisapride The metabolism of Cisapride can be decreased when combined with Venlafaxine. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Venlafaxine is combined with Gabapentin. |
Fluvastatin | Fluvastatin The metabolism of Venlafaxine can be decreased when combined with Fluvastatin. |
Fluvoxamine | Fluvoxamine The metabolism of Venlafaxine can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The metabolism of Nefazodone can be decreased when combined with Venlafaxine. |
Lamotrigine | Lamotrigine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lamotrigine. |
Losartan | Losartan The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Tramadol. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Venlafaxine can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Venlafaxine can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection Venlafaxine may decrease the excretion rate of Ifosfamide which could result in a higher serum level. |
Nicardipine | Nicardipine The metabolism of Venlafaxine can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The risk or severity of seizure can be increased when Venlafaxine is combined with Bupropion. |
Ticlopidine | Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Venlafaxine. |
Saquinavir | Saquinavir The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Venlafaxine. |
Metformin | Metformin The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Metformin. |
Dalteparin Injection | Dalteparin Injection Venlafaxine may increase the antiplatelet activities of Dalteparin. |
Nisoldipine | Nisoldipine Venlafaxine may decrease the excretion rate of Nisoldipine which could result in a higher serum level. |
Lamivudine | Lamivudine Venlafaxine may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Venlafaxine is combined with Riluzole. |
Acarbose | Acarbose The risk or severity of hypoglycemia can be increased when Acarbose is combined with Venlafaxine. |
Glimepiride | Glimepiride The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Venlafaxine. |
Gemcitabine Injection | Gemcitabine Injection Venlafaxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Indinavir | Indinavir The serum concentration of Indinavir can be decreased when it is combined with Venlafaxine. |
Ritonavir | Ritonavir The serum concentration of Venlafaxine can be increased when it is combined with Ritonavir. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Venlafaxine may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Venlafaxine. |
Zafirlukast | Zafirlukast The metabolism of Venlafaxine can be decreased when combined with Zafirlukast. |
Fosfomycin | Fosfomycin Venlafaxine may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine Venlafaxine may increase the serotonergic activities of Mirtazapine. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Venlafaxine. |
Zileuton | Zileuton The metabolism of Zileuton can be decreased when combined with Venlafaxine. |
Valsartan | Valsartan The metabolism of Venlafaxine can be decreased when combined with Valsartan. |
Insulin Lispro Injection | Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Venlafaxine. |
Pramipexole | Pramipexole Venlafaxine may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The metabolism of Donepezil can be decreased when combined with Venlafaxine. |
Nelfinavir | Nelfinavir The metabolism of Venlafaxine can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Azithromycin. |
Carvedilol | Carvedilol The metabolism of Carvedilol can be decreased when combined with Venlafaxine. |
Nilutamide | Nilutamide The metabolism of Venlafaxine can be decreased when combined with Nilutamide. |
Flutamide | Flutamide Venlafaxine may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline The metabolism of Selegiline can be decreased when combined with Venlafaxine. |
Bicalutamide | Bicalutamide The metabolism of Venlafaxine can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The metabolism of Sertraline can be decreased when combined with Venlafaxine. |
Propafenone | Propafenone The serum concentration of Venlafaxine can be increased when it is combined with Propafenone. |
Raloxifene | Raloxifene Venlafaxine may increase the excretion rate of Raloxifene which could result in a lower serum level and potentially a reduction in efficacy. |
Irbesartan | Irbesartan The metabolism of Irbesartan can be decreased when combined with Venlafaxine. |
Tamsulosin | Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Venlafaxine. |
Ropinirole | Ropinirole Venlafaxine may increase the sedative activities of Ropinirole. |
Quetiapine | Quetiapine The metabolism of Quetiapine can be decreased when combined with Venlafaxine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cetirizine. |
Paroxetine | Paroxetine The metabolism of Paroxetine can be decreased when combined with Venlafaxine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tolcapone. |
Citalopram | Citalopram The metabolism of Venlafaxine can be decreased when combined with Citalopram. |
Capecitabine | Capecitabine The metabolism of Venlafaxine can be decreased when combined with Capecitabine. |
Efavirenz | Efavirenz The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Efavirenz. |
Abacavir | Abacavir Venlafaxine may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil The metabolism of Sildenafil can be decreased when combined with Venlafaxine. |
Pioglitazone | Pioglitazone The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pioglitazone. |
Celecoxib | Celecoxib The risk or severity of bleeding can be increased when Celecoxib is combined with Venlafaxine. |
Rosiglitazone | Rosiglitazone The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Rosiglitazone. |
Tolterodine | Tolterodine The metabolism of Tolterodine can be decreased when combined with Venlafaxine. |
Thalidomide | Thalidomide Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Venlafaxine which could result in a higher serum level. |
Balsalazide | Balsalazide Venlafaxine may increase the antiplatelet activities of Balsalazide. |
Nateglinide | Nateglinide The metabolism of Nateglinide can be decreased when combined with Venlafaxine. |
Galantamine | Galantamine The metabolism of Galantamine can be decreased when combined with Venlafaxine. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levetiracetam. |
Rabeprazole | Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Venlafaxine. |
Terbinafine | Terbinafine The metabolism of Venlafaxine can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists